Evidence map›Paper›PMID 27125883›Full record

Trial reportAlimentary pharmacology & therapeutics2016

Randomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipation.

A Erdogan, S S C Rao, D Thiruvaiyaru, Y Y Lee, E Coss Adame, J Valestin, M O'Banion

Registry-linked trialOpen access · bronzeAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Alimentary pharmacology & therapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04716868 (Prospective, Randomized and Controlled Study for the Evaluation of the Effectiveness of a Supplement of Agave Tequilana Weber Var. Azul Fiber Derivatives vs Psyllium Plantago in Patients With Functional Constipation), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04716868 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Prospective, Randomized and Controlled Study for the Evaluation of the Effectiveness of a Supplement of Agave Tequilana Weber Var. Azul Fiber Derivatives vs Psyllium Plantago in Patients With Functional Constipation

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2019 to 2021Enrolled60ConditionsFunctional ConstipationArmsAgave Fructans 5 g, Agave Fructans 10 g, Agave Fructans 5 g + Maltodextrin 10 g, Psyllium plantago
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. [Seoul Consensus on Clinical Practice Guidelines for Functional Constipation].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2025
    Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Fiber-rich snacks improved constipation in Vietnamese elderly.Asia Pacific journal of clinical nutrition · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

A ErdoganDivision of Gastroenterology and Hepatology, Augusta University, Augusta, GA, USA.
S S C RaoDivision of Gastroenterology and Hepatology, Augusta University, Augusta, GA, USA.
D ThiruvaiyaruCollege of Science & Mathematics, Augusta University, Augusta, GA, USA.
Y Y LeeDivision of Gastroenterology and Hepatology, Augusta University, Augusta, GA, USA.ORCID 0000-0002-6486-7717
E Coss AdameDivision of Gastroenterology and Hepatology, Augusta University, Augusta, GA, USA.
J ValestinUniversity of Iowa, Iowa City, IA, USA.
M O'BanionDivision of Gastroenterology and Hepatology, Augusta University, Augusta, GA, USA.
Augusta University · USUniversity of Iowa · US

Funding

Cytokines and the blood-brain barrier in the ovine fetusR01HD057100 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI STONESTREET, BARBARA S · 2008 to 2020
$3.8M
Novel Treatment Strategies for Constipation and Role of Brain-Gut axisR01DK057100 · NIDDK · UNIVERSITY OF IOWA · PI RAO, SATISH SC · 2000 to 2011
$2.7M
NICHD NIH HHS R01 HD057100NIDDK NIH HHS R01 DK057100
6 · The paper itself

Abstract

backgroundFibre supplements are useful, but whether a plum-derived mixed fibre that contains both soluble and insoluble fibre improves constipation is unknown.

aimTo investigate the efficacy and tolerability of mixed soluble/insoluble fibre vs. psyllium in a randomized double-blind controlled trial.

methodsConstipated patients (Rome III) received mixed fibre or psyllium, 5 g b.d., for 4 weeks. Daily symptoms and stool habit were assessed using stool diary. Subjects with ≥1 complete spontaneous bowel movement/week above baseline for ≥2/4 weeks were considered responders. Secondary outcome measures included stool consistency, bowel satisfaction, straining, gas, bloating, taste, dissolvability and quality of life (QoL).

resultsSeventy-two subjects (mixed fibre = 40; psyllium = 32) were enrolled and two from psyllium group withdrew. The mean complete spontaneous bowel movement/week increased with both mixed fibre (P < 0.0001) and psyllium (P = 0.0002) without group difference. There were 30 (75%) responders with mixed fibre and 24 (75%) with psyllium (P = 0.9). Stool consistency increased (P = 0.04), straining (P = 0.006) and bloating scores decreased (P = 0.02) without group differences. Significantly more patients reported improvement in flatulence (53% vs. 25%, P = 0.01) and felt that mixed fibre dissolved better (P = 0.02) compared to psyllium. QoL improved (P = 0.0125) with both treatments without group differences.

conclusionsMixed fibre and psyllium were equally efficacious in improving constipation and QoL. Mixed fibre was more effective in relieving flatulence, bloating and dissolved better. Mixed fibre is effective and well tolerated.

Indexed as

Quality of LifeAdultConstipationDefecationDietary FiberDouble-Blind MethodFemaleFlatulenceHumansLaxativesMalePsylliumTreatment OutcomeDietary FiberLaxativesPsyllium

Identifiers

PMID27125883
PMCPMC4891216
OpenAlexW2344656436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.